ANALYSIS OF THE GENE EXPRESSION OF SPARC AND ITS PROGNOSTIC VALUE FOR BLADDER CANCER
- 1 December 2001
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 166 (6), 2495-2499
- https://doi.org/10.1016/s0022-5347(05)65623-6
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Osteonectin/SPARC is overexpressed in human hepatocellular carcinomaThe Journal of Pathology, 1999
- Regulation of human monocyte matrix metalloproteinases by SPARCJournal of Cellular Physiology, 1997
- Terms of attachment: SPARC and tumorigenesisNature Medicine, 1997
- Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cellsNature Medicine, 1997
- Distribution of SPARC in normal and neoplastic human tissue.Journal of Histochemistry & Cytochemistry, 1995
- Neoplastic progression of human colorectal cancer is associated with overexpression of the stromelysin‐3 and BM‐40/SPARC genesInternational Journal of Cancer, 1995
- SPARC is a source of copper-binding peptides that stimulate angiogenesis.The Journal of cell biology, 1994
- SPARC, a secreted protein associated with morphogenesis and tissue remodeling, induces expression of metalloproteinases in fibroblasts through a novel extracellular matrix-dependent pathway.The Journal of cell biology, 1993
- Molecular analysis of the cDNA for human SPARC/osteonectin/BM-40: Sequence, expression, and localization of the gene to chromosome 5q31-q33Genomics, 1988
- Invasive Bladder Cancer: Tumor Configuration, Lymphatic Invasion and SurvivalJournal of Urology, 1983